J&J's Xarelto to get fast FDA review of new uses; German Merck threatens Portugal over unpaid bills;

 @FiercePharma: ‪Merck‬ KGaA says it'll stop investing in R&D in Portugal if drug bills don't get paid. More | Follow @FiercePharma

> Bayer and Johnson & Johnson's ($JNJ) clot-fighting drug Xarelto got on the FDA fast track for new indications in deep vein thrombosis and pulmonary embolism. Report

> Merck KGaA is threatening to cut off future R&D investment in Portugal if the country doesn't start paying its drug bills. More

> Sucampo Pharmaceuticals is trying to mend fences with its partner Takeda after losing a legal bid to dissolve their marketing deal on Amitiza, a constipation drug. Report

> Indian officials may bar drugmakers from offering gifts and hospitality to doctors, expanding on current rules that outlaw doctors' acceptance of pharma-industry favors. Report

> Australia's Mayne Pharma saw its shares suffer after Mylan Pharmaceuticals challenged Mayne and Warner Chilcott's exclusive hold on the prescription antibiotic Doryx. Article

Biotech News

@FierceBiotech: Australian ‪cancer‬ ‪biotech‬ spin-out Alchemia pitches $60M ‪IPO‬ stateside. More | Follow @FierceBiotech

@JohnCFierce: Israel's RDD Pharma raised a bit more than $7M from Orbimed to develop drugs delivered up the anal canal. More | Follow @JohnCFierce

 @RyanMFierce: Biotech‬ Genkyotex nails down $26M to fund drug for diabetic kidney disease. More | Follow @RyanMFierce

> Rival sources tangle over claim that Celgene is mulling 'horrid' HGS bid. Article

> Experimental vaccine knocks the weight off flabby mice. More

> Dissidents trigger big shake up at QLT after board coup. News

Medical Device News

@FierceMedDev: Luminex snaps up diagnostics firm GenturaDx for $50M in cash. Item | Follow @FierceMedDev

 @MarkHFierce: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @MarkHFierce

 @DamianFierce: Stryker is recalling two all-metal hip implants after reports of corrosion and failure. More | Follow @DamianFierce

> Qiagen gets FDA nod for colorectal cancer Dx. News

> Timeline: The industry gets serious about device hacking. Editor's Corner

> Cook snags 510(k) for colonic stent. More

> Devicemaker CartiHeal pulls in $10M financing round. Article

Biotech IT News

> Mount Sinai Medical Center, Cloudera embrace Big Data in genomics. Story

> Voice software offers potential tool for clinical trials. Article

> ERT scoops up Invivodata for ePRO clinical trials tech. More

> Mytrus aligns leadership for at-home clinical trials biz. News

And Finally... As some drugmakers pull out of brain-drug research, others see promise in hallucinogenics such as ketamine. Report